Legal status in the United States

Is Rapamycin legal?

Read at FDA, DEA and WADAPublished by PepVault

Rapamycin (sirolimus) is FDA-approved (Rapamune, first in 1999), is not a federally controlled substance, and is not named on WADA’s Prohibited List, as of November 19, 2026.

Rapamycin at a glance

CheckStatus, read Nov 19, 2026
FDA approvalApproved (Rapamune, 1999)
CompoundingNot checked yet
DEA scheduleNot controlled
Sport (WADA)Not named on the list

FDA approval

Sirolimus, the drug name for rapamycin, is FDA-approved, first as Rapamune oral solution in 1999 and Rapamune tablets in 2000, to prevent organ rejection in people 13 and older receiving a kidney transplant and to treat lymphangioleiomyomatosis (LAM); generic sirolimus tablets are sold under later applications. Drugs@FDA also lists sirolimus as a gel (Hyftor), a cream (Scomara) and a powder for injection (Fyarro). Its use for longevity is off-label.

A smiling man in a grey t-shirt in his living room, holding his phone

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Compounding

Not checked yet. We could not settle this at its primary source on November 19, 2026, so the page leaves it out rather than guess.

DEA schedule

It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

Sport (WADA)

WADA’s 2026 Prohibited List doesn’t name sirolimus or rapamycin, and it is an approved drug, so S0, the class for unapproved substances, doesn’t reach it.

What this means and doesn’t

This page reports what the agencies’ own pages said about Rapamycin in the United States when we read them on November 19, 2026. These are records of regulators, not study evidence; for what the research shows, see the compound page.

It is not legal advice, and it doesn’t cover state laws or other countries, whose rules differ. Agencies change their lists, so each fact carries its date and a link to the page it came from.

Questions

  • Is Rapamycin FDA approved?

    Sirolimus, the drug name for rapamycin, is FDA-approved, first as Rapamune oral solution in 1999 and Rapamune tablets in 2000, to prevent organ rejection in people 13 and older receiving a kidney transplant and to treat lymphangioleiomyomatosis (LAM); generic sirolimus tablets are sold under later applications. Drugs@FDA also lists sirolimus as a gel (Hyftor), a cream (Scomara) and a powder for injection (Fyarro). Its use for longevity is off-label.

  • Is Rapamycin a controlled substance?

    It is not a federally controlled substance: its name is not in the DEA’s schedules (21 CFR Part 1308) or on the DEA’s alphabetical list of controlled substances.

  • Is Rapamycin banned in sport?

    WADA’s 2026 Prohibited List doesn’t name sirolimus or rapamycin, and it is an approved drug, so S0, the class for unapproved substances, doesn’t reach it.

Read next

Track it in the app

PepVault for iPhone

Keep your own record in PepVault

Log your doses and vials, with a reminder for the next one.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo